Project Details
Description
MT2023-34 A Safety and Effectiveness Registry Study of Patients with B-Thalassemia Treated with Betibeglogene Autotemcel
| Status | Active |
|---|---|
| Effective start/end date | 9/14/23 → 9/30/33 |
Funding
- BLUEBIRD BIO, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.